125 related articles for article (PubMed ID: 9544580)
1. Urinary levels of chemokines (MCAF/MCP-1, IL-8) reflect distinct disease activities and phases of human IgA nephropathy.
Yokoyama H; Wada T; Furuichi K; Segawa C; Shimizu M; Kobayashi K; Su S; Mukaida N; Matsushima K
J Leukoc Biol; 1998 Apr; 63(4):493-9. PubMed ID: 9544580
[TBL] [Abstract][Full Text] [Related]
2. [The role of monocyte chemotactic and activating factor (MCAF)/monocyte chemoattractant protein (MCP)-1 in subgroups of rapidly progressive glomerulonephritis].
Sakai N; Wada T; Furuichi K; Takaeda C; Shimizu M; Iwata Y; Yoshimoto K; Shimizu K; Kobayashi K; Takeda S; Kida H; Mukaida N; Matsushima K; Yokoyama H
Nihon Jinzo Gakkai Shi; 1999 Oct; 41(7):704-11. PubMed ID: 10572396
[TBL] [Abstract][Full Text] [Related]
3. Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis.
Wada T; Yokoyama H; Su SB; Mukaida N; Iwano M; Dohi K; Takahashi Y; Sasaki T; Furuichi K; Segawa C; Hisada Y; Ohta S; Takasawa K; Kobayashi K; Matsushima K
Kidney Int; 1996 Mar; 49(3):761-7. PubMed ID: 8648917
[TBL] [Abstract][Full Text] [Related]
4. Value of urinary levels of interleukin-6, epidermal growth factor, monocyte chemoattractant protein type1 and transforming growth factor β1 in predicting the extent of fibrosis lesions in kidney biopsies of patients with IgA nephropathy.
Segarra-Medrano A; Carnicer-Caceres C; Valtierra-Carmeno N; Agraz-Pamplona I; Ramos-Terrades N; Jatem Escalante E; Ostos-Roldan E
Nefrologia; 2017; 37(5):531-538. PubMed ID: 28946966
[TBL] [Abstract][Full Text] [Related]
5. Monocyte chemotactic peptide-1 expression in acute and chronic human nephritides: a pathogenetic role in interstitial monocytes recruitment.
Grandaliano G; Gesualdo L; Ranieri E; Monno R; Montinaro V; Marra F; Schena FP
J Am Soc Nephrol; 1996 Jun; 7(6):906-13. PubMed ID: 8793800
[TBL] [Abstract][Full Text] [Related]
6. CC chemokines and chemokine receptors in IgA nephropathy (IgAN) and in non-IgA mesangial proliferative glomerulonephritis (MesProGN). the immunohistochemical comparative study.
Wagrowska-Danilewicz M; Danilewicz M; Stasikowska O
Pol J Pathol; 2005; 56(3):121-6. PubMed ID: 16334979
[TBL] [Abstract][Full Text] [Related]
7. Urinary levels of epidermal growth factor, interleukin-6 and monocyte chemoattractant protein-1 may act as predictor markers of renal function outcome in immunoglobulin A nephropathy.
Stangou M; Alexopoulos E; Papagianni A; Pantzaki A; Bantis C; Dovas S; Economidou D; Leontsini M; Memmos D
Nephrology (Carlton); 2009 Sep; 14(6):613-20. PubMed ID: 19143943
[TBL] [Abstract][Full Text] [Related]
8. Glomerular expression of C-C chemokines in different types of human crescentic glomerulonephritis.
Liu ZH; Chen SF; Zhou H; Chen HP; Li LS
Nephrol Dial Transplant; 2003 Aug; 18(8):1526-34. PubMed ID: 12897090
[TBL] [Abstract][Full Text] [Related]
9. [Study of correlation between urinary IL-6 level and mesangial lesion in childhood onset IgA nephropathy].
Akutsu Y
Hokkaido Igaku Zasshi; 1994 Jul; 69(4):686-96. PubMed ID: 7959587
[TBL] [Abstract][Full Text] [Related]
10. MIP-1alpha and MCP-1 contribute to crescents and interstitial lesions in human crescentic glomerulonephritis.
Wada T; Furuichi K; Segawa-Takaeda C; Shimizu M; Sakai N; Takeda SI; Takasawa K; Kida H; Kobayashi KI; Mukaida N; Ohmoto Y; Matsushima K; Yokoyama H
Kidney Int; 1999 Sep; 56(3):995-1003. PubMed ID: 10469367
[TBL] [Abstract][Full Text] [Related]
11. Clinical and immunohistochemical study of immunoglobulin A nephropathy (IgAN) before and after tonsillectomy.
Abe K; Miyazaki M; Shioshita K; Harada T; Koji T; Kohno S
Acta Otolaryngol Suppl; 2004 Dec; (555):20-4. PubMed ID: 15768792
[TBL] [Abstract][Full Text] [Related]
12. Urinary IL-6/EGF ratio: a useful prognostic marker for the progression of renal damage in IgA nephropathy.
Ranieri E; Gesualdo L; Petrarulo F; Schena FP
Kidney Int; 1996 Dec; 50(6):1990-2001. PubMed ID: 8943482
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1), chemokines essentially involved in inflammatory and immune reactions.
Mukaida N; Harada A; Matsushima K
Cytokine Growth Factor Rev; 1998 Mar; 9(1):9-23. PubMed ID: 9720753
[TBL] [Abstract][Full Text] [Related]
14. Urinary Exosomes and Exosomal CCL2 mRNA as Biomarkers of Active Histologic Injury in IgA Nephropathy.
Feng Y; Lv LL; Wu WJ; Li ZL; Chen J; Ni HF; Zhou LT; Tang TT; Wang FM; Wang B; Chen PS; Crowley SD; Liu BC
Am J Pathol; 2018 Nov; 188(11):2542-2552. PubMed ID: 30142333
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of activated human mesangial cell proliferation by the natural product of Cordyceps sinensis (H1-A): an implication for treatment of IgA mesangial nephropathy.
Lin CY; Ku FM; Kuo YC; Chen CF; Chen WP; Chen A; Shiao MS
J Lab Clin Med; 1999 Jan; 133(1):55-63. PubMed ID: 10385482
[TBL] [Abstract][Full Text] [Related]
16. Combinatorial model of chemokine involvement in glomerular monocyte recruitment: role of CXC chemokine receptor 2 in infiltration during nephrotoxic nephritis.
Zernecke A; Weber KS; Erwig LP; Kluth DC; Schröppel B; Rees AJ; Weber C
J Immunol; 2001 May; 166(9):5755-62. PubMed ID: 11313419
[TBL] [Abstract][Full Text] [Related]
17. MiR-100-3p and miR-877-3p regulate overproduction of IL-8 and IL-1β in mesangial cells activated by secretory IgA from IgA nephropathy patients.
Liang Y; Zhao G; Tang L; Zhang J; Li T; Liu Z
Exp Cell Res; 2016 Oct; 347(2):312-21. PubMed ID: 27542871
[TBL] [Abstract][Full Text] [Related]
18. Tubular and interstitial expression of ICAM-1 as a marker of renal injury in IgA nephropathy.
Arrizabalaga P; Solé M; Abellana R; de las Cuevas X; Soler J; Pascual J; Ascaso C
Am J Nephrol; 2003; 23(3):121-8. PubMed ID: 12566693
[TBL] [Abstract][Full Text] [Related]
19. Mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy.
Fabiano RCG; de Almeida Araújo S; Bambirra EA; Oliveira EA; Simões E Silva AC; Pinheiro SVB
Pediatr Nephrol; 2017 Jul; 32(7):1211-1220. PubMed ID: 28233100
[TBL] [Abstract][Full Text] [Related]
20. Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction.
Matsumori A; Furukawa Y; Hashimoto T; Yoshida A; Ono K; Shioi T; Okada M; Iwasaki A; Nishio R; Matsushima K; Sasayama S
J Mol Cell Cardiol; 1997 Jan; 29(1):419-23. PubMed ID: 9040055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
